The first 'post-Coronavirus' PrevaCamp event was held in Olmoti in the Masai region of northern Tanzania in December 2020. In a very well attended event, more than 600 participants were screened for signs of lymphoma, prostate, breast and cervical cancer. Three suspected lymphoma cases were identified.